Karl Hofbauer

Title: The Innovative Contributions of Karl Hofbauer

Introduction

Karl Hofbauer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of four patents to his name, Hofbauer's work has the potential to impact various medical conditions.

Latest Patents

Hofbauer's latest patents include groundbreaking inventions related to monoclonal antibodies. One of his patents focuses on antibodies against tropomyosin-related kinase B receptors. This invention involves monoclonal antibodies directed to a specific part of the TrkB receptor and hybridoma cell lines that produce these antibodies. The fragments of these antibodies, especially those representing complementarity determining regions (CDRs), are useful in treating cancer, pain, anorexia, anorexia nervosa, and cachexia. Another significant patent involves monoclonal antibodies directed to the human melanocortin-4 receptor. This invention includes binding fragments and derivatives aimed at treating cachexia and related conditions, along with pharmaceutical compositions that utilize these antibodies.

Career Highlights

Hofbauer has worked with prestigious institutions, including the University of Basel and Universitaet Basel. His research and innovations have positioned him as a key figure in the biotechnology sector. His work is characterized by a commitment to advancing medical treatments through innovative antibody therapies.

Collaborations

Hofbauer has collaborated with notable individuals in his field, including Jean-Christophe Peter. These collaborations have likely contributed to the success and development of his innovative patents.

Conclusion

Karl Hofbauer's contributions to biotechnology through his patents on monoclonal antibodies demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of various medical conditions.